揭露囊性肉瘤:一种罕见的诊断复杂性和治疗抵抗性的罕见病例
Abid Nawaz Khan Adil1, Bakht Rehman1, Syed S Raza1,2
1Internal Medicine, Community Medical Center, Fresno, USA.
Cureus
|April 22, 2025
概括
囊性肉瘤 (HS) 是一种罕见的癌症,起源于免疫细胞. 本案例报告详细介绍了诊断和管理方面的挑战,强调了由于非最佳结果和限制治疗选择的特定遗传突变而需要新的治疗方法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 囊性肉瘤 (HS) 是一种罕见且具有攻击性的血液性恶性瘤.
- 它起源于巨细胞或单细胞血统.
- HS通常以胃肠道或软组织中的质量呈现.
研究的目的:
- 突出诊断和管理囊细胞肉瘤的临床挑战.
- 讨论免疫组织化学和分子研究在准确诊断中的作用.
- 强调对HS新型治疗方法的需求.
主要方法:
- 一个37岁的HS女患者的病例报告.
- 对包括免疫组织化学和分子研究在内的诊断方法的审查.
- 描述多式疗法:化疗,向疗法和放射疗法.
主要成果:
- 患者经历了疾病进展,尽管多式疗法.
- 准确的诊断需要先进的诊断技术.
- 确定了ARID2突变,影响了治疗选择.
结论:
- 囊性肉瘤带来了重大的诊断和管理挑战.
- 目前对HS的治疗结果仍然不够理想.
- 存在ARID2突变可能会限制某些疗法的疗效,例如免疫检查点抑制剂,因此需要开发新的治疗策略.
关键词:
诊断挑战的复杂性是一个挑战.囊细胞性肉瘤 (histiocytic sarcoma) 是一种表皮细胞性肉瘤.免疫检查点抑制剂 免疫检查点抑制剂免疫组织化学和活检.治疗性抗药性是一种治疗性抗药性.更多相关视频
04:21Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry
Published on: January 26, 2024
612
07:52Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
19.6K
相关概念视频
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K